等待开盘 10-16 09:30:00 美东时间
+0.860
+2.22%
The Greenlight Capital funds returned -4.3% in the second quarter of 2026 and 1.9% year-to-date, each net of fees and expenses, compared to 15.2% for the S&P 500 index for the quarter and 10.2% year-t...
10-13 21:20
今日重点评级关注:巴克莱:上调Vertical Aerospace评级至"标配",目标价从2美元降至1美元;巴克莱:维持Bitdeer Technologies"超配"评级,目标价从15美元升至17美元
10-12 14:52
今日重点评级关注:DA Davidson:维持美光科技"买入"评级,目标价从2100美元升至3000美元;Leerink Partners:维持OmniAb"跑赢大市"评级,目标价从10美元升至12美元
10-08 12:30
RBC Capital Markets在第三季度财报季前对建筑产品板块转趋谨慎,下调盈利预测并调降多只个股评级,因高利率、通胀及疲软的住房需求可能延续至202...
10-08 11:38
今日重点评级关注:Jones Trading:维持Opus Genetics"买入"评级,目标价从10美元升至17美元;Citizens:维持Rezolute"跑赢大市"评级,目标价从11美元升至15美元
10-07 17:30
Barclays analyst Matthew Bouley maintains Fortune Brands (NYSE:FBIN) with a Equal-Weight and lowers the price target from $54 to $47.
10-06 21:44
Fortune Brands Innovations (FBIN) declares $0.26/share quarterly dividend, in line with previous. Forward yield 2.71% Payable Dec. 9; for shareholders of record Nov. 20; ex-div Nov. 20. See FBIN Divid...
09-30 04:14
今日重点评级关注:古根海姆:维持Damora Therapeutics"买入"评级,目标价从40美元升至60美元;HC Wainwright & Co.:维持Rezolute"买入"评级,目标价从5美元升至10美元
09-28 12:37
Evercore ISI Group analyst Stephen Kim maintains Fortune Brands (NYSE:FBIN) with a In-Line and lowers the price target from $56 to $45.
09-25 22:42
今日重点评级关注:Ascendiant Capital:维持Outlook Therapeutics"买入"评级,目标价从10美元升至10.5美元;摩根士丹利:维持Aurora Innovation"超配"评级,目标价从14美元升至18美元
09-14 16:05